婴儿胆汁淤积性肝病严重程度与血清维生素D水平的关系

黄彩芝; 聂波丽; 唐莲; 莫丽亚

doi:10.3969/j.issn.1001-5256.2019.08.026

婴儿胆汁淤积性肝病严重程度与血清维生素D水平的关系

DOI: 10.3969/j.issn.1001-5256.2019.08.026

湖南省儿童医院

详细信息

中图分类号: R725.7
计量
- 文章访问数: 1319
- HTML全文浏览量: 46
- PDF下载量: 231
- 被引次数: 0
出版历程
- 收稿日期: 2019-03-14
- 出版日期: 2019-08-20

Correlation of severity of infantile cholestatic liver disease with serum vitamin D level

Hunan Children’s Hospital

摘要

摘要:
目的探讨血清25羟基维生素D[25（OH） D]水平与婴儿胆汁淤积性肝病（ICH）患儿病情严重程度的关系。方法选取2015年7月-2017年12月收入或转入湖南省儿童医院肝病中心的121例ICH患儿作为研究对象,根据是否发生肝硬化分为肝硬化组（26例）和无肝硬化组（95例）,对2组患儿的年龄、性别比、25（OH） D、肝功能指标（TBil、DBil、总蛋白、Alb、ALT、AST、GGT、ALP、总胆汁酸、PT）、肝纤维化血清学指标[Ⅲ型前胶原氨基端肽、层粘连蛋白、透明质酸（HA）、Ⅳ型胶原（CⅣ）]以及与维生素D代谢有关的指标（Ca、P）等进行比较。计量资料两组间比较采用独立样本t检验或Mann-Whitney U非参数秩和检验,计数资料组间比较采用χ2检验。应用二分类logistic回归分析与肝硬化发生有关的因素。结果 ICH患儿中维生素D缺乏者占88. 43%（107/121）,肝硬化患儿中维生素D缺乏者占100%（26/26）;与无肝硬化组比较,肝硬化组血清25（OH） D（Z=3. 029,P=0. 002）、Alb水平明显降低（t=2. 294,P=0. 024）,DBil...
- 胆汁淤积 /
- 维生素D /
- 婴儿
Abstract:
Objective To investigate the correlation of serum 25-hydroxy vitamin D[25 (OH) D]level with the severity of infantile cholestatic hepatopathy (ICH) . Methods A total of 121 infants with ICH who were admitted or referred to Liver Research Center in our hospital from July 2015 to December 2017 were enrolled, and according to the presence or absence of liver cirrhosis, these infants were divided into liver cirrhosis group with 26 infants and non-liver cirrhosis group with 95 infants. The two groups were compared in terms of age, sex ratio, 25 (OH) D, liver function parameters [total bilirubin (TBil) , direct bilirubin (DBil) , total protein (TP) , albumin (Alb) , alanine aminotransferase (ALT) , aspartate aminotransferase (AST) , gamma-glutamyl transpeptidase (GGT) , alkaline phosphatase (ALP) , total bile acid (TBA) , and prothrombin time (PT) ], serological markers of liver fibrosis [procollagen Ⅲ peptide (PⅢNP) , laminin (LN) , hyaluronic acid (HA) , and type Ⅳ collagen (C-Ⅳ) ], and indices associated with vitamin D metabolism (Ca and P) . The independent samples t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. A binary logistic regression analysis was used to investigate the factors associated with the development of liver cirrhosis. Results Of all 121 infants, 107 (88. 43%) had vitamin D deficiency, and all 26 infants with liver cirrhosis had vitamin D deficiency. Compared with the non-liver cirrhosis group, the liver cirrhosis group had significant reductions in the serum levels of 25 (OH) D and Alb (Z = 3. 029, t = 2. 294, P < 0. 05) and significant increases in the levels of DBil, AST, GGT, HA, and C-Ⅳ (Z = 3. 032, 2. 026, 3. 439, 3. 143, and 2. 247, P < 0. 05) , while there were no significant differences in the other indices between the two groups (all P > 0. 05) . The multivariate logistic regression analysis showed that 25 (OH) D (odds ratio [OR]= 0. 865, 95% confidence interval [CI]: 0. 755-0. 922, P = 0. 038) , GGT (OR = 1. 002, 95% CI: 1. 000-1. 004, P = 0. 039) , and HA (OR = 1. 004, 95% CI: 1. 000-1. 008, P = 0. 034) were associated with liver cirrhosis in infants with ICH. Conclusion Serum 25 (OH) D has a certain clinical value in predicting the severity of hepatocyte damage and the development of early liver cirrhosis in infants with ICH.
- cholestasis /
- vitamin D /
- infant

HTML全文

参考文献(14)

[1] ZHANG QD, LU LG. Mechanisms and treatment of cholestasisinduced liver fibrosis[J]. J Clin Hepatol, 2015, 31 (3) :337-341. (in Chinese) 张启迪, 陆伦根.胆汁淤积致肝纤维化的机制及治疗[J].临床肝胆病杂志, 2015, 31 (3) :337-341.

[2] YANG BB, CHEN YH, ZHANG C, et al. Low vitamin D status is associated with advanced liver fibrosis in patients with nonalcoholic fatty liver disease[J]. Endocrine, 2017, 55 (2) :582-590.

[3] SAVIC'ˇZ, VRACˇARIC'V, MILIC'N, et al. Vitamin D supplementation in patients with alcoholic liver cirrhosis:A prospective study[J]. Minerva Med, 2018, 109 (5) :352-357.

[4] KO BJ, KIM YS, KIM SG, et al. Relationship between 25-hydroxyvitamin D levels and liver fibrosis as assessed by transient elastography in patients with chronic liver disease[J].Gut Liver, 2016, 10 (5) :818-825.

[5] LIAO Q, WAN CM, ZHU Y, et al. Current status of research on infantile cholestatic liver disease in China:A visualization analysis[J]. Chin J Contemp Pediatr, 2017, 19 (5) :529-533. (in Chinese) 廖琼, 万朝敏, 朱渝, 等.婴儿胆汁淤积性肝病在中国的研究现状的可视化分析[J].中国当代儿科杂志, 2017, 19 (5) :529-533.

[6] FAWAZ R, BAUMANN U, EKONG U, et al. Guideline for the evaluation of cholestatic jaundice in infants:Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition[J].JPGN, 2017, 64 (1) :154-168.

[7] Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J]. Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会, 中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.

[8] CHEN EQ, SHI Y, TANG H. New insight of vitamin D in chronic liver diseases[J]. Hepatobiliary Pancreat Dis Int, 2014, 13 (6) :580-585.

[9] SAMRA NM, EMAD EI ABRAK S, EI DASH HH, et al. Evaluation of vitamin D status bone mineral density and dental health in children with cholestasis[J]. Clin Res Hepatol Gastroenterol, 2018, 42 (4) :368-377.

[10] JIANG C, HUANG HY, LYU GY. Perspectives of liver transplantation for infantile cholestatic liver disease[J]. J Clin Hepatol, 2017, 33 (10) :1928-1930. (in Chinese) 蒋超, 黄鹤宇, 吕国悦.婴儿胆汁淤积性肝病肝移植展望[J].临床肝胆病杂志, 2017, 33 (10) :1928-1930.

[11] REITER FP, HOHENESTER S, NAGEL JM, et al. 1, 25- (OH) 2-vitamin D-prevents activation of hepatic stellate cells in vitro and ameliorates inflammatory liver damage but not fibrosis in the Abcb4 (-/-) model[J]. Biochem Biophys Res Commun, 2015, 459 (2) :227-233.

[12] ABDELGHANY AH, BASALAMAH MA, IDRIS S, et al. The fibrolytic potentials of vitamin D and thymoquinone remedial therapies:Insights from liver fibrosis established by CCl4in rats[J]. J Transl Med, 2016, 14 (1) :281.

[13] PATERNOSTRO R, WAGNER D, REIBERGER T, et al. Low25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis[J].Wien Klin Wochenschr, 2017, 129 (1-2) :8-15.

[14] KUMAR R, KUMAR P, SAXENA KN, et al. Vitamin D status in patients with cirrhosis of the liver and their relatives-A case control study from North India[J]. Indian J Gastroenterol, 2017, 36 (1) :50-55.

施引文献

资源附件(0)

访问统计